Managed Access Programs for TQJ230, Pelacarsen
NCT07000695 · Status: AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2025-06-03
Summary
The purpose of this registration is to list Managed Access Programs (MAPs) related to TQJ230, pelacarsen
Conditions
- Atherosclerotic Cardiovascular Disease, ASCVD
Interventions
- DRUG
-
Pelacarsen
Patients receive Pelacarsen
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
Topical Nitro or Placebo Pre-Cath
NCT06289946 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes
NCT06469528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
NCT00799903 ·Status: COMPLETED ·Phase: PHASE3
-
Angiogenesis Using VEGF-A165/bFGF Plasmid Delivered Percutaneously in No-option CAD Patients; a Controlled Trial
NCT00620217 ·Status: COMPLETED ·Phase: PHASE2
-
Early Aortic Valve Lipoprotein(a) Lowering Trial
NCT02109614 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
NCT02586155 ·Status: COMPLETED ·Phase: PHASE3
-
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
NCT01975389 ·Status: TERMINATED ·Phase: PHASE3
-
Lovaza Therapy of Peripheral Arterial Disease
NCT00569686 ·Status: WITHDRAWN ·Phase: NA
-
A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease
NCT01609140 ·Status: COMPLETED ·Phase: PHASE2
-
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
NCT06909565 ·Status: RECRUITING ·Phase: PHASE4
-
In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme
NCT06675994 ·Status: NOT_YET_RECRUITING
-
A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)
NCT01294709 ·Status: COMPLETED ·Phase: PHASE1
-
The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease
NCT05009862 ·Status: COMPLETED ·Phase: PHASE4
-
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
NCT02956993 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
NCT06292013 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy of LCQ908 on Cardiovascular Risk
NCT01474434 ·Status: TERMINATED ·Phase: PHASE2
-
To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients When Given With an Experimental Injection Catheter
NCT00090714 ·Status: UNKNOWN ·Phase: PHASE2
-
Rosiglitazone Therapy In The Prevention Of Coronary Artery Disease In Patients With Impaired Glucose Tolerance
NCT00733174 ·Status: UNKNOWN ·Phase: PHASE4
-
Rosiglitazone Versus Placebo in Chronic Stable Angina
NCT00225355 ·Status: TERMINATED ·Phase: PHASE4
-
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
NCT07293260 ·Status: RECRUITING ·Phase: PHASE3
-
Study of microRNAs in the Evolution of Carotid Plaque. Physiopathological and Therapeutic Interest
NCT03149406 ·Status: UNKNOWN
-
Silencing Inflammatory Activity by Injecting Nanocort in Patients at Risk for Atherosclerotic Disease
NCT01601106 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
PGD2 Formation in Vascular Injury
NCT01001260 ·Status: TERMINATED
-
The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes
NCT01165983 ·Status: COMPLETED ·Phase: NA
-
Carotid Plaque Screening Trial in Smokers
NCT00548665 ·Status: COMPLETED ·Phase: PHASE4